Top

Published in:

01-09-2013 | Original Article

Outcome of GreenLight HPS laser therapy in surgically high-risk patients

Authors: Chien Hsu Chen, Shung Eing Lin, Po Hui Chiang

Published in: Lasers in Medical Science | Issue 5/2013

Abstract

The aims of this study are to present our experience with GreenLight HPS laser in the treatment of benign prostatic hyperplasia (BPH) and evaluate the outcomes of laser therapy in surgically high-risk patients. This study included a total of 132 patients who were treated for BPH by using GreenLight HPS laser between August 2008 and December 2010 by the same operator. These patients were further divided into five subgroups: group A (age ≧ 80 years), group B (prostate volume ≧ 80 ml), group C (American Society of Anesthesiologists score = 3), group D (anticoagulant use), and group E (non-A, non-B, non-C, and non-D patients). Data on International Prostate Symptom Score, maximum flow rate (Q _max), post-void residual urine, and quality-of-life score were evaluated at baseline and at 1, 12, and 24 months after surgery. The result showed that group B patients required a longer lasing time during surgery. In addition, longer post-operative catheterization time and hospital stay were noted in groups B, C, and D patients. Statistically significant improvements were noted post-operatively for all functional parameters in all groups. The proportion of secondary surgery was significantly higher in group B patients. No major complication was observed in all groups. This suggested that GreenLight HPS laser is safe and effective in the treatment of surgically high-risk patients.

Malek RS, Kuntzman RS, Barrett DM (2000) High power potassium–titanyl–phosphate laser vaporization prostatectomy. J Urol 163(6):1730–1733PubMedCrossRef

Te AE (2006) The next generation in laser treatments and the role of the Greenlight high-performance system laser. Rev Urol 8(suppl 3):S24–S30PubMed

Woo H, Reich O, Bachmann A et al (2008) Outcome of greenlight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (≧ 80 ml). EurUrol (suppl) 7:378–383

Kang HW, Jebens D, Malek RS et al (2008) Laser vaporization of bovine prostate: a quantitative comparison of 532 nm GreenLight 80-W potassium–titanyl–phosphate and 120-W lithium triborate lasers. J Urol 180:2675–2680PubMedCrossRef

Malek RS, Kang HW, Coad JE et al (2009) Greenlight photoselective 120-Watt 532-nm lithium triborate laser vaporization prostatectomy in living canine. J Endourol 23:837–845PubMedCrossRef

Capitán C, Blázquez C, Martin MD et al (2011) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 60(4):734–739PubMedCrossRef

Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:349–355PubMedCrossRef

Chiang PH, Chen CH, Kang CH et al (2010) GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med 42:624–629PubMedCrossRef

Ruszat R, Seitz M, Wyler SF et al (2009) Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 104:820–825PubMedCrossRef

10.

Woo HH, Hossack TA (2011) Photoselective vaporization for prostatic obstruction with the 120-W lithium triborate laser: 1-year clinical outcomes. Int J Urol 18:162–165PubMedCrossRef

11.

Spaliviero M, Araki M, Culkin DJ et al (2009) Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 23(3):495–502PubMedCrossRef

12.

Matlaga BR, Kim SC, Kuo RL, Watkins SL, Lingeman JE (2006) Holmium laser enucleation of the prostate for prostates of >125 mL. BJU Int 97:81–84PubMedCrossRef

13.

Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53:160–166PubMedCrossRef

14.

Naspro R, Suardi N, Salonia A et al (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50:563–568PubMedCrossRef

15.

Gu X, Strom K, Spaliviero M et al (2012) Does age affect the efficacy and safety of GreenLightHPS(™) laser photoselective vaporization prostatectomy? Aging Male 15(1):63–67PubMedCrossRef

16.

Gu X, Vricella GJ, Spaliviero M et al (2012) Does size really matter? The impact of prostate volume on the efficacy and safety of GreenLight HPS™ laser photoselective vaporization of the prostate. J Endourol 26(5):525–530PubMedCrossRef

17.

Taşçı AI, Ilbey YO, Luleci H et al (2011) 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology 78:134–140PubMedCrossRef

18.

Spaliviero M, Araki M, Wong C (2008) Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 22:2341–2347PubMedCrossRef

19.

Elzayat EA, Habib EI, Elhilali MM (2005) Holmium laser enucleation of the prostate: a size-independent new “gold standard”. Urology 66:108–113PubMedCrossRef

20.

Seitz M, Reich O, Gratzke C et al (2009) High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 24(2):172–178PubMedCrossRef

21.

Chen CH, Chiang PH, Chuang YC et al (2010) Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology 75:658–663PubMedCrossRef

22.

Chiang PH, Chen CH (2010) Prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-w high-intensity diode laser. Curr Urol Rep 11(4):249–253PubMedCrossRef

23.

Woo HH, Hossack TA (2011) Photoselective vaporization of the prostate with the 120-W lithium triborate laser in men taking Coumadin. Urology 78(1):142–145PubMedCrossRef

Title: Outcome of GreenLight HPS laser therapy in surgically high-risk patients
Authors: Chien Hsu Chen
Shung Eing Lin
Po Hui Chiang
Publication date: 01-09-2013
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 5/2013
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-012-1234-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Outcome of GreenLight HPS laser therapy in surgically high-risk patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Effects of different surface treatments on shear bond strength in two different ceramic systems

Quantitative optical coherence tomography of fluid-filled oral mucosal lesions

Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing

Influence of photoactivation method and mold for restoration on the Knoop hardness of resin composite restorations

BMLA Abstracts 2013

Topical photodynamic therapy using transfersomal aluminum phthalocyanine tetrasulfonate: in vitro and in vivo study